Brind.

Rapt Therapeutics announced significant management changes and partnerships, including Brian Wong as CEO and a trial partnership with Jemincare.

2 reports, 1 independent Updated Aug 7
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Rapt Therapeutics announced significant management changes and partnerships, including Brian Wong as CEO and a trial partnership with Jemincare.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireRAPT Therapeutics Reports Second Quarter 2025 Financial Results SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clin
  • Unknown outlet